Human small-cell lung cancers show amplification and expression of the N-myc gene
- PMID: 2869482
- PMCID: PMC323017
- DOI: 10.1073/pnas.83.4.1092
Human small-cell lung cancers show amplification and expression of the N-myc gene
Abstract
We have found that 6 of 31 independently derived human small-cell lung cancer (SCLC) cell lines have 5- to 170-fold amplified N-myc gene sequences. The amplification is seen with probes from two separate exons of N-myc, which are homologous to either the second or the third exon of the c-myc gene. Amplified N-myc sequences were found in a tumor cell line started prior to chemotherapy, in SCLC tumor samples harvested directly from tumor metastases at autopsy, and from a resected primary lung cancer. Several N-myc-amplified tumor cell lines also exhibited N-myc hybridizing fragments not in the germ-line position. In one patient's tumor, an additional amplified N-myc DNA fragment was observed and this fragment was heterogenously distributed in liver metastases. In contrast to SCLC with neuroendocrine properties, no non-small-cell lung cancer lines examined were found to have N-myc amplification. Fragments encoding two N-myc exons also detect increased amounts of a 3.1-kilobase N-myc mRNA in N-myc-amplified SCLC lines and in one cell line that does not show N-myc gene amplification. Both DNA and RNA hybridization experiments show that in any one SCLC cell line, only one myc-related gene is amplified and expressed. We conclude that N-myc amplification is both common and potentially significant in the tumorigenesis or tumor progression of SCLC.
Similar articles
-
L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer.Nature. 1985 Nov 7-13;318(6041):69-73. doi: 10.1038/318069a0. Nature. 1985. PMID: 2997622
-
Sequence of a germ-line N-myc gene and amplification as a mechanism of activation.Oncogene. 1988 Apr;2(4):399-402. Oncogene. 1988. PMID: 2834684
-
Amplification and expression of protooncogenes in human small cell lung cancer cell lines.Cancer Res. 1987 Dec 1;47(23):6236-42. Cancer Res. 1987. PMID: 2824028
-
Amplification and rearrangement of L-myc in human small-cell lung cancer.Mutat Res. 1992 May;276(3):307-15. doi: 10.1016/0165-1110(92)90017-4. Mutat Res. 1992. PMID: 1374523 Review.
-
Amplification of cellular oncogenes: a predictor of clinical outcome in human cancer.Genes Chromosomes Cancer. 1990 Jan;1(3):181-93. doi: 10.1002/gcc.2870010302. Genes Chromosomes Cancer. 1990. PMID: 1982063 Review.
Cited by
-
Overexpression of MYCN promotes proliferation of non-small cell lung cancer.Tumour Biol. 2016 Sep;37(9):12855-12866. doi: 10.1007/s13277-016-5236-2. Epub 2016 Jul 23. Tumour Biol. 2016. PMID: 27449038
-
Human neuroblastoma cell lines as models for the in vitro study of neoplastic and neuronal cell differentiation.Environ Health Perspect. 1989 Mar;80:3-15. doi: 10.1289/ehp.89803. Environ Health Perspect. 1989. PMID: 2538324 Free PMC article. Review.
-
MYCN and Metabolic Reprogramming in Neuroblastoma.Cancers (Basel). 2022 Aug 25;14(17):4113. doi: 10.3390/cancers14174113. Cancers (Basel). 2022. PMID: 36077650 Free PMC article. Review.
-
N-myc oncogene amplification in paediatric tumours.Ir J Med Sci. 1990 Jun;159(6):172-4. doi: 10.1007/BF02937236. Ir J Med Sci. 1990. PMID: 2172180
-
Human cancer and cellular oncogenes.Biochem J. 1987 Apr 15;243(2):313-27. doi: 10.1042/bj2430313. Biochem J. 1987. PMID: 3307760 Free PMC article. Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical